In non-small cell lung cancer (NSCLC), NEAT1 can inhibit apoptosis and induce paclitaxel resistance in NSCLC cells by inhibiting the expression of apoptosis-related proteins cleaved caspase3 and cleaved PARP and activating the AKT/mTOR signaling pathway [53, 54]. Here, AKT1 is linked to non-small cell lung carcinoma.